ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Supply of chronic Mechanical Circulatory Support (MCS)

Universitair Medisch Centrum Groningen (UMCG) · Onderhandeling zonder bekendmaking · 1 lots · 355920
Type
Supplies
33182000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

University Medical Center Groningen (UMCG) announces that for the period from 1 January 2025 to 31 December 2027 (with a possible extension until 31 December 2028), it intends to award a single-source, negotiated contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) devices, specifically the Left Ventricular Assist Device (Heartmate™ 3). The procedure is based on an exception to the obligation to tender (Article 2.32 paragraph 1 sub b2 AW) because no reasonable alternative or substitute is available. This announcement serves to inform the market in advance and to provide stakeholders with the opportunity to lodge an objection within 20 calendar days. If no objection is submitted, the right to challenge the procedure expires.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderMechanical Circulatory SupportHeartmate 3MCS

01What is being requested

University Medical Center Groningen (UMCG) announces that for the period from 1 January 2025 to 31 December 2027 (with a possible extension until 31 December 2028), it intends to award a single-source, negotiated contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) devices, specifically the Left Ventricular Assist Device (Heartmate™ 3). The procedure is based on an exception to the obligation to tender (Article 2.32 paragraph 1 sub b2 AW) because no reasonable alternative or substitute is available. This announcement serves to inform the market in advance and to provide stakeholders with the opportunity to lodge an objection within 20 calendar days. If no objection is submitted, the right to challenge the procedure expires.

This concerns the announcement in the case of voluntary prior transparency of the intention to award the contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) in the form of the Left Ventricular Assist Device (Heartmate™ 3) from 01-01-2025 up to and including 31-12-2027, with the possibility of an extension of 1 year (up to and including 31-12-2028). Based on an exception to the obligation to tender, the contract may be awarded via a single-source negotiated procedure, and UMCG relies on Article 2.32 paragraph 1 sub b2 AW for this purpose. Compe

33182000Supplies
1Supply of chronic Mechanical Circulatory Support (MCS)

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1Medtronic Trading NL B.V.SME9630×
2Boston Scientific Nederland B.V.SME9320×
3Meyra Retail & Services B.V.SME8821×
4Abbott Medical Nederland B.V.SME8716×
5Johnson & Johnson Medical B.V.SME8416×
6Philips Nederland B.V.SME8215×

05Legal themes that may be relevant here

06Frequently asked questions

What is the intended duration of the supply of the MCS equipment?
The contract runs from 1 January 2025 up to and including 31 December 2027, with a possible extension up to and including 31 December 2028.
Which specific medical equipment does the contract concern?
The contract concerns the supply of chronic Mechanical Circulatory Support (MCS) in the form of the Left Ventricular Assist Device (Heartmate™ 3).
How can stakeholders object to the intended procedure?
Stakeholders can submit a reasoned objection via the email address in the contact details within 20 calendar days after publication of the announcement.
What is the reason for the chosen procedure without competition?
There is an exception to the obligation to tender because no reasonable alternative or substitute is available for the required equipment.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528